High persistence of biologic therapy in patients with Psoriatic arthritis: a real-world evidence from a high-complexity hospital in Colombia

Few studies described PsA patients treated with biologics in Latin America, making these findings a valuable contribution on biologic usage and persistence patterns in Colombia, with a high persistence population. The results highlight the heterogeneity of this disease and the need for personalized, continuous management guided by specialists.